PL363355A1 - Sposób wytwarzania chinolonów i naftyrydyn drogą cyklizacji - Google Patents

Sposób wytwarzania chinolonów i naftyrydyn drogą cyklizacji

Info

Publication number
PL363355A1
PL363355A1 PL01363355A PL36335501A PL363355A1 PL 363355 A1 PL363355 A1 PL 363355A1 PL 01363355 A PL01363355 A PL 01363355A PL 36335501 A PL36335501 A PL 36335501A PL 363355 A1 PL363355 A1 PL 363355A1
Authority
PL
Poland
Prior art keywords
making
naphthyridines
quinolones
process step
cyclization process
Prior art date
Application number
PL01363355A
Other languages
English (en)
Other versions
PL207394B1 (pl
Inventor
Sreenivasa Reddy Mundla
Jared Lynn Randall
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL363355A1 publication Critical patent/PL363355A1/pl
Publication of PL207394B1 publication Critical patent/PL207394B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL363355A 2000-12-14 2001-12-07 Sposób wytwarzania chinolonów i naftyrydyn PL207394B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines

Publications (2)

Publication Number Publication Date
PL363355A1 true PL363355A1 (pl) 2004-11-15
PL207394B1 PL207394B1 (pl) 2010-12-31

Family

ID=22969207

Family Applications (1)

Application Number Title Priority Date Filing Date
PL363355A PL207394B1 (pl) 2000-12-14 2001-12-07 Sposób wytwarzania chinolonów i naftyrydyn

Country Status (19)

Country Link
EP (1) EP1343766B1 (pl)
JP (2) JP4417007B2 (pl)
KR (1) KR100603163B1 (pl)
CN (1) CN1232508C (pl)
AT (1) ATE300522T1 (pl)
AU (2) AU2002229057B2 (pl)
BR (1) BR0116229A (pl)
CA (1) CA2427831C (pl)
CZ (1) CZ20031379A3 (pl)
DE (1) DE60112325T2 (pl)
DK (1) DK1343766T3 (pl)
ES (1) ES2247190T3 (pl)
HU (1) HUP0303991A3 (pl)
IL (2) IL155677A0 (pl)
MX (1) MXPA03005338A (pl)
NO (1) NO325236B1 (pl)
NZ (1) NZ525569A (pl)
PL (1) PL207394B1 (pl)
WO (1) WO2002048113A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
DE60329318D1 (de) * 2002-11-20 2009-10-29 Japan Tobacco Inc 4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
CA2645119C (en) 2006-03-06 2012-01-24 Japan Tobacco Inc. Method for producing 4-oxoquinoline compound
IN2014CN00532A (pl) 2006-03-06 2015-04-03 Japan Tobacco Inc
WO2008033836A2 (en) * 2006-09-12 2008-03-20 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
TR201820964T4 (tr) 2008-07-01 2019-01-21 Taigen Biotechnology Co Ltd Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi.
PT2880017T (pt) 2012-08-03 2016-12-14 Gilead Sciences Inc Processo e intermediários para preparar inibidores da integrase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9700872A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para producir antimicrobianos de quinolonil-lactama y compuestos intermediarios novedosos.
NZ290721A (en) * 1994-08-02 1999-03-29 Procter & Gamble Process for making quinolone-containing antimicrobial compounds

Also Published As

Publication number Publication date
ATE300522T1 (de) 2005-08-15
KR20030063420A (ko) 2003-07-28
DE60112325D1 (de) 2005-09-01
AU2002229057B2 (en) 2005-04-21
ES2247190T3 (es) 2006-03-01
CA2427831C (en) 2009-08-18
BR0116229A (pt) 2003-11-04
EP1343766A1 (en) 2003-09-17
HUP0303991A3 (en) 2012-09-28
MXPA03005338A (es) 2003-10-06
NO325236B1 (no) 2008-03-03
DK1343766T3 (da) 2005-10-31
NO20032667D0 (no) 2003-06-12
DE60112325T2 (de) 2006-05-24
CZ20031379A3 (cs) 2003-11-12
NO20032667L (no) 2003-08-14
IL155677A0 (en) 2003-11-23
HUP0303991A2 (hu) 2004-04-28
JP2004515542A (ja) 2004-05-27
PL207394B1 (pl) 2010-12-31
CN1232508C (zh) 2005-12-21
EP1343766B1 (en) 2005-07-27
IL155677A (en) 2009-02-11
NZ525569A (en) 2004-09-24
CA2427831A1 (en) 2002-06-20
WO2002048113A1 (en) 2002-06-20
KR100603163B1 (ko) 2006-07-24
JP4417007B2 (ja) 2010-02-17
CN1481365A (zh) 2004-03-10
AU2905702A (en) 2002-06-24
JP2010001315A (ja) 2010-01-07

Similar Documents

Publication Publication Date Title
RS86804A (en) Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents
AU2905702A (en) Cyclization process step in the making of quinolones and naphthyridines
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
WO2003018588A3 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
IL154014A0 (en) Process for the preparation of 2-aminoethylpyridines
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
IL156141A0 (en) A process for the preparation of taxan derivatives
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
IN187760B (pl)
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
AU2002233708A1 (en) Process for producing quinoline-3-carboxylic acid compound
IL185920A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
TR200001819T2 (tr) COPD tedavi yöntemi.
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
HU0201262D0 (pl)
TR200200995T2 (tr) 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses.
MXPA04003519A (es) Procedimiento para la preparacion del 14beta-hidroxi-bacatina iii-1,14-carbonato.
SE0000382D0 (sv) New process
WO2003044877A3 (en) Light emitting device and compounds for use therein
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
UA42307A (uk) 4-диметиламіно-3-формілбензойна кислота та спосіб її одержання
YU52602A (sh) Postupak za pripremanje estara aril-iminometil-karbaminske kiseline
AUPR080300A0 (en) Improvement to mobile (cellular) phone refered to as "the brett test"
PL368635A1 (pl) Sposób wytwarzania paliwa o niskiej zawartości popiołu
HU0101842D0 (en) Korturek variety of tearose hybrid (rosa l.)

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
LAPS Decisions on the lapse of the protection rights

Effective date: 20121207